ヘルスケア株
| # | 過去7日 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2977 |  TECX Tectonic Therapeutic, Inc. - Common Stock | 21.30 USD | +1.62% | -6.33% | -24.33% | +24.20% | 416.40 M USD | ||
| 2979 |  MYGN Myriad Genetics, Inc. - Common Stock | 4.35 USD | +4.82% | +4.07% | +11.83% | -47.40% | 416.08 M USD | ||
| 2982 |  RCEL Avita Medical, Inc. - Common Stock | 13.41 USD | +2.37% | -0.59% | +25.92% | +211.86% | 414.73 M USD | ||
| 2984 |  DRUG Bright Minds Biosciences Inc. - common stock | 54.21 USD | +6.90% | +4.43% | -9.92% | -17.48% | 413.94 M USD | ||
| 2988 |  ZURA Zura Bio Limited - Class A Ordinary shares | 4.28 USD | -2.95% | +3.63% | -9.32% | +28.53% | 410.15 M USD | ||
| 2990 |  EIKN Eikon Therapeutics, Inc. - Common Stock | 7.54 USD | +7.56% | +0.80% | -12.83% | -55.78% | 408.40 M USD | ||
| 2991 |  TKNO Alpha Teknova, Inc. - Common Stock | 7.60 USD | -2.44% | -10.38% | +2.70% | +47.00% | 408.03 M USD | ||
| 2996 |  SPRY ARS Pharmaceuticals, Inc. - Common Stock | 4.07 USD | +3.56% | -10.55% | -4.46% | -55.81% | 404.75 M USD | ||
| 2997 |  CTEV Claritev Corporation Class A Common Stock | 23.86 USD | -0.58% | -4.14% | -29.41% | +3.97% | 404.37 M USD | ||
| 3014 |  OFIX Orthofix Medical Inc. - Common Stock | 9.59 USD | +3.68% | +6.56% | +7.27% | -39.95% | 390.63 M USD | ||
| 3019 |  SRTA Strata Critical Medical, Inc. - Class A Common Stock | 4.34 USD | +1.40% | -2.91% | -18.11% | -13.20% | 383.95 M USD | ||
| 3025 |  SI Shoulder Innovations, Inc. Common Stock | 18.39 USD | +2.74% | +1.88% | +0.33% | +51.36% | 382.86 M USD | ||
| 3031 |  CARL Carlsmed, Inc. - Common Stock | 13.95 USD | +0.72% | -0.36% | -10.40% | +4.49% | 380.87 M USD | ||
| 3034 |  INDP Indaptus Therapeutics, Inc. - Common Stock | 2.85 USD | +28.96% | +21.28% | -13.37% | +50.00% | 379.74 M USD | ||
| 3037 |  RZLT Rezolute, Inc. - Common Stock | 3.90 USD | -7.80% | -15.22% | -4.65% | -55.58% | 377.22 M USD | ||
| 3043 |  EDIT Editas Medicine, Inc. - Common Stock | 2.44 USD | +7.49% | -12.86% | -12.86% | -36.79% | 374.74 M USD | ||
| 3045 |  SLP Simulations Plus, Inc. - Common Stock | 18.50 USD | 0.00% | 0.00% | +0.43% | +3.53% | 374.16 M USD | ||
| 3046 |  GALT Galectin Therapeutics Inc. - Common Stock | 3.71 USD | +1.92% | +1.92% | -0.54% | -26.53% | 374.15 M USD | ||
| 3049 |  MPLT MapLight Therapeutics, Inc. - Common Stock | 8.02 USD | +2.69% | -12.35% | -30.68% | -57.79% | 371.95 M USD | ||
| 3050 |  VMD Viemed Healthcare, Inc. - Common Shares | 9.75 USD | +0.62% | +3.94% | +9.06% | +43.38% | 371.36 M USD |
ニュース ヘルスケア株
MacroGenics、進行固形腫瘍患者を対象とした、非開示標的に向けた抗体薬物複合体MGC030の第1相試験で最初の患者への投与を開始
木曜日の取引中に動いたヘルスケア株12銘柄
Dyadic Internationalの13G提出書類は、Empery Asset Managementが9月30日時点で同社株式8.35%を保有していると報告していることを示す
NeurAxis、医療ポリシーの適用対象が2,600万人超の医療保険加入者に拡大したと発表
Edesa Biotech、尋常性白斑におけるEB06の第2相臨床試験に関する治験薬（IND）申請についてFDAの承認を取得
Wedbush、Sutro Biopharmaの「アウトパフォーム」を再確認、目標株価60ドルを維持
ゼネティック・バイオサイエンシズ、提携先のPeriNessがイスラエルで大細胞B細胞リンパ腫治療を目的とした全身投与型組換えヒトDNaseの臨床試験で最初の参加者に投与したと発表
上昇銘柄ヘルスケア株
 ESLA Estrella Immunopharma, Inc. - Common Stock | 0.54 | +68.75% |
 DRMA Dermata Therapeutics, Inc. - Common Stock | 0.91 | +37.88% |
INDP Indaptus Therapeutics, Inc. - Common Stock | 2.85 | +28.96% |
 HUMA Humacyte, Inc. - Common Stock | 0.44 | +25.71% |
 NMRA Neumora Therapeutics, Inc. - Common Stock | 0.43 | +22.86% |
 PIIIW P3 Health Partners Inc. - Warrant | 0.0072 | +20.00% |
 TRIB Trinity Biotech plc - American Depositary Shares each represent | 7.93 | +19.97% |
 AKTX Akari Therapeutics Plc - American Depositary Shares | 8.67 | +19.75% |
下落銘柄ヘルスケア株
 SPRC SciSparc Ltd. - Ordinary Shares | 2.00 | -44.75% |
 CDIOW Cardio Diagnostics Holdings Inc. - Warrant | 0.0064 | -28.09% |
 NXGLW NexGel, Inc - Warrant | 0.0065 | -27.78% |
 DRTSW Alpha Tau Medical Ltd. - Warrant | 2.9900 | -17.40% |
 PFSA Profusa, Inc. - Common Stock | 1.07 | -16.41% |
 MDAIW Spectral AI, Inc. - Warrants | 0.4100 | -16.33% |
 CDTTW CDT Equity Inc. - Warrant | 0.0061 | -15.28% |
 PTN Palatin Technologies, Inc. Common Stock | 6.49 | -15.27% |